Go
View All
Proposed risk categories for primary soft tissue sarcomas
Prostate cancer
Pseudomyxoma peritonei
pT1 is defined as tumor limited to testis (including rete testis invasion) without lymphovascular invasion
pT2 is defined as tumor limited to testis (including rete testis invasion) with lymphovascular invasion (shown here) or tumor invading hilar soft tissue, epididymis or penetrating visceral mesothelial layer covering the external surface of tunica albuginea with or without lymphovascular invasion (shown here)
pT2 is defined as tumor limited to testis (including rete testis invasion) with lymphovascular invasion or tumor invading hilar soft tissue (shown here), epididymis (shown here) or penetrating visceral mesothelial layer covering the external surface of tunica albuginea with or without lymphovascular invasion
PTH
PTT
Radiation Therapy Oncology Group (RTOG)
Recommendation for the diagnostic evaluation of children with NHL
Recommendations for the diagnostic evaluation of patients with lymphoma
Rectal carcinoma
Recurrence-free and overall survival for patients treated with 1 versus 3 years of imatinib for higher-risk GIST, defined as having at least one of the following features: (1) longest tumor diameter greater than 10
Recurrent cytogenetic abnormalities in adult ALL and their prognostic significance,,-
Recurrent cytogenetic abnormalities in childhood ALL and their prognostic significance
Regional lymph node (N)
Regional lymph nodes for skin sites of the head and neck
Regional lymph nodes for the cervix uteri
Regional lymph nodes for the vagina
Regional lymph nodes of ovary, fallopian tube and primary peritoneal carcinomas
Regional lymph nodes of the adrenal gland
Regional lymph nodes of the corpus uteri
Regional lymph nodes of the kidney
Regional lymph nodes of the penis
Regional lymph nodes of the pleura
Regional lymph nodes of the stomach
Regional lymph nodes of the testis
Displaying items 451 - 480 of 1114